Trials / Completed
CompletedNCT05083299
Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate
Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate on Symptom Improvement in Patients With Peripheral Arterial Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,003 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years – 80 Years
- Healthy volunteers
- —
Summary
The study will evaluate the effect of Anpl-one SR Tablet on the improvement of symptoms in daily care environments using PAQ.
Detailed description
The purpose of this study is to evaluate the effect of Anple-one SR Tablet on the improvement of symptoms in daily care environments within the scope of 300 milligrams of Anpl-one SR Tablet (sarpogrelate hydrochloride agent) using PAQ.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sarpogrelate | Anpl-one SR |
Timeline
- Start date
- 2020-01-28
- Primary completion
- 2022-01-20
- Completion
- 2022-01-20
- First posted
- 2021-10-19
- Last updated
- 2024-07-03
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05083299. Inclusion in this directory is not an endorsement.